Cytosorbents Corporation (CTSO)
Largest Insider Buys in Sector
CTSO Stock Price History Chart
CTSO Stock Performance
About Cytosorbents Corporation
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention and treatment of perioperative complications of cardiopulmonary bypass surgery, and maintaining or enhancing the quality of solid organs harvested from donors for organ transplant. The company also develops VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals; CytoSorb-XL, a device for adjunctive therapy in the treatment of sepsis and other critical illnesses; HemoDefend blood purification technology platform to reduce contaminants in the blood supply that can cause transfusion reactions or disease when administering blood and blood products to patients, as well as removal of anti-A and anti-B blood group antibodies from fresh whole blood and plasma; K+ontrol for treatment of severe hyperkalemia in patients with life-threatening conditions; and ContrastSorb for the removal of IV contrast in blood administered during CT imaging, an angiogram, or during a vascular interventional radiology procedure to reduce the risk of contrast-induced nephropathy. In addition, it is involved in the development of BetaSorb, a device for the prevention and treatment of health complications caused by the accumulation of metabolic toxins in patients with chronic renal failure; DrugSorb, a device to remove toxic chemicals from the blood; and DrugSorb-ATR, an antithrombotic removal system. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey.
Insider Activity of Cytosorbents Corporation
Over the last 12 months, insiders at Cytosorbents Corporation have bought $314,582 and sold $0 worth of Cytosorbents Corporation stock.
On average, over the past 5 years, insiders at Cytosorbents Corporation have bought $180,793 and sold $76,551 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Chan Phillip P. (Chief Executive Officer) — $100,000. BATOR MICHAEL G. (director) — $59,580. BLOCH KATHLEEN P. (Chief Financial Officer) — $50,000.
The last purchase of 75,188 shares for transaction amount of $100,000 was made by Chan Phillip P. (Chief Executive Officer) on 2023‑12‑13.
List of Insider Buy and Sell Transactions, Cytosorbents Corporation
| 2023-12-13 | Chan Phillip P. | Chief Executive Officer | 75,188 0.129% | $1.33 | $100,000 | -45.25% | ||
| 2023-12-13 | Capponi Vincent | President & COO | 18,797 0.0322% | $1.33 | $25,000 | -45.25% | ||
| 2023-12-13 | BLOCH KATHLEEN P. | Chief Financial Officer | 37,594 0.0645% | $1.33 | $50,000 | -45.25% | ||
| 2023-12-13 | Deliargyris Efthymios | Chief Medical Officer | 22,557 0.0387% | $1.33 | $30,001 | -45.25% | ||
| 2023-12-13 | BATOR MICHAEL G. | director | 37,594 0.0645% | $1.33 | $50,000 | -45.25% | ||
| 2023-12-13 | Sobel Alan D. | director | 22,557 0.0387% | $1.33 | $30,001 | -45.25% | ||
| 2023-12-13 | Jones Edward Raymond | director | 7,519 0.0129% | $1.33 | $10,000 | -45.25% | ||
| 2023-12-13 | Kim Jiny | director | 7,519 0.0129% | $1.33 | $10,000 | -45.25% | ||
| 2023-08-07 | BATOR MICHAEL G. | director | 2,000 0.0046% | $3.17 | $6,350 | -67.47% | ||
| 2023-08-04 | BATOR MICHAEL G. | director | 1,000 0.0023% | $3.23 | $3,230 | -68.13% | ||
| 2023-05-25 | BLOCH KATHLEEN P. | Interim CFO | 3,300 0.0076% | $2.85 | $9,389 | -51.31% | ||
| 2023-05-10 | BLOCH KATHLEEN P. | Interim CFO | 10,000 0.0212% | $3.11 | $31,058 | -54.17% | ||
| 2022-12-08 | Chan Phillip P. | Chief Executive Officer | 5,859 0.0136% | $1.26 | $7,382 | +121.60% | ||
| 2022-12-07 | Chan Phillip P. | Chief Executive Officer | 9,850 0.0221% | $1.26 | $12,411 | +114.73% | ||
| 2022-12-06 | Chan Phillip P. | Chief Executive Officer | 14,291 0.0324% | $1.26 | $18,064 | +116.41% | ||
| 2022-08-25 | Kim Jiny | 1,000 0.0021% | $1.91 | $1,910 | +33.82% | |||
| 2022-06-21 | Capponi Vincent | President and COO | 2,000 0.0047% | $1.80 | $3,600 | +22.73% | ||
| 2022-06-16 | Chan Phillip P. | Chief Executive Officer | 2,221 0.005% | $1.85 | $4,109 | +14.44% | ||
| 2022-06-16 | Capponi Vincent | See Remarks | 3,000 0.0074% | $2.00 | $6,000 | +14.44% | ||
| 2022-06-09 | Chan Phillip P. | Chief Executive Officer | 16,000 0.0366% | $2.17 | $34,784 | -2.29% |
Insider Historical Profitability
| Chan Phillip P. | Chief Executive Officer | 1068704 2.0469% | $0.78 | 15 | 4 | +34.83% |
| Capponi Vincent | President & COO | 584134 1.1188% | $0.78 | 5 | 16 | +26.1% |
| BLOCH KATHLEEN P. | Chief Financial Officer | 467941 0.8962% | $0.78 | 15 | 11 | +6.75% |
| Deliargyris Efthymios | Chief Medical Officer | 348433 0.6673% | $0.78 | 1 | 0 | |
| BATOR MICHAEL G. | director | 125394 0.2402% | $0.78 | 6 | 0 | +22.88% |
| Sobel Alan D. | director | 101857 0.1951% | $0.78 | 2 | 0 | +5.67% |
| Jones Edward Raymond | director | 88834 0.1701% | $0.78 | 3 | 0 | +30% |
| Kim Jiny | director | 77819 0.149% | $0.78 | 2 | 0 | +33.82% |
| Lamadrid David | Chief Financial Officer | 7837500 15.011% | $0.78 | 0 | 2 | |
| NJTC INVESTMENT FUND, LP | 10 percent owner | 4870218 9.3278% | $0.78 | 0 | 10 | |
| Kraus Al | 130046 0.2491% | $0.78 | 1 | 52 | +9.68% | |
| Mortensen Eric R. | Chief Medical Officer | 2500 0.0048% | $0.78 | 1 | 0 | +65.82% |
| BERGER RONALD | See Remarks | 69 0.0001% | $0.78 | 4 | 0 | <0.0001% |
| Gunton James T. | 2 0% | $0.78 | 0 | 10 |
Institutional Investor Ownership
| Avenir Corp | $3.01M | 5.84 | 3.17M | +3.98% | +$115,229.29 | 0.26 | |
| Granahan Investment Management | $2.89M | 5.61 | 3.04M | -15.85% | -$544,644.43 | 0.1 | |
| Skylands Capital LLC | $2.73M | 5.3 | 2.88M | -11.64% | -$359,727.90 | 0.38 | |
| The Vanguard Group | $1.85M | 3.59 | 1.95M | 0% | +$0 | <0.0001 | |
| Neuberger Berman | $1.81M | 3.52 | 1.91M | +6.15% | +$104,971.70 | <0.01 | |
| Sargent Investment Group Llc | $1.3M | 2.52 | 1.37M | +4.4% | +$54,693.40 | 0.3 | |
| Cm Management Llc | $783,750.00 | 1.52 | 825,000 | +98.8% | +$389,500.00 | 0.04 | |
| BlackRock | $686,313.00 | 1.33 | 722,435 | -0.54% | -$3,690.75 | <0.0001 | |
| Geode Capital Management | $416,474.00 | 0.81 | 438,297 | +20.11% | +$69,723.53 | <0.0001 | |
| Cibc Private Wealth Group Llc | $156,938.00 | 0.32 | 172,649 | 0% | +$0 | <0.0001 | |
| State Street | $133,278.00 | 0.26 | 140,293 | -7.15% | -$10,259.97 | <0.0001 | |
| Morgan Stanley | $110,566.00 | 0.21 | 116,385 | -3% | -$3,413.36 | <0.0001 | |
| Advisor Group Holdings Inc | $108,120.00 | 0.21 | 113,810 | +0.98% | +$1,045.01 | <0.0001 | |
| Renaissance Technologies | $76,000.00 | 0.15 | 79,620 | -54.59% | -$91,348.91 | <0.0001 | |
| Northern Trust | $71,262.00 | 0.14 | 75,013 | 0% | +$0 | <0.0001 | |
| Raymond James Financial Services Advisors Inc | $57,561.00 | 0.11 | 60,591 | 0% | +$0 | <0.0001 | |
| Raymond James Associates | $47,500.00 | 0.09 | 50,000 | 0% | +$0 | <0.0001 | |
| Jane Street Capital | $44,322.00 | 0.09 | 46,655 | New | +$44,322.00 | <0.0001 | |
| Stifel | $42,750.00 | 0.08 | 45,000 | 0% | +$0 | <0.0001 | |
| Bank of America | $35,053.00 | 0.07 | 36,898 | -44.75% | -$28,387.82 | <0.0001 | |
| Millennium Management LLC | $34,051.00 | 0.07 | 35,843 | -20.57% | -$8,820.79 | <0.0001 | |
| Key Client Fiduciary Advisors Llc | $32,829.00 | 0.06 | 34,557 | New | +$32,829.00 | 0.01 | |
| Chicago Partners Wealth Advisors | $26,956.00 | 0.06 | 30,667 | -0.55% | -$148.55 | <0.01 | |
| Texas Capital Bank Wealth Management Services Inc | $22,008.00 | 0.04 | 23,166 | -24.46% | -$7,125.10 | <0.01 | |
| Creative Planning | $20,230.00 | 0.04 | 21,295 | 0% | +$0 | <0.0001 | |
| Johnson Investment Counsel Inc | $18,418.00 | 0.04 | 19,387 | -2.92% | -$554.81 | <0.0001 | |
| Granite Springs Asset Management Llc | $18,003.00 | 0.04 | 18,950 | 0% | +$0 | 0.02 | |
| Susquehanna International Group | $15,388.00 | 0.03 | 16,198 | New | +$15,388.00 | <0.0001 | |
| Resources Investment Advisors Inc | $14,250.00 | 0.03 | 15,000 | 0% | +$0 | <0.0001 | |
| Country Club Bank Gfn | $14,463.00 | 0.03 | 15,225 | 0% | +$0 | <0.01 | |
| SEI Investments Company | $13,850.00 | 0.03 | 14,471 | +39.13% | +$3,895.34 | <0.0001 | |
| Regal Investment Advisors | $10,934.00 | 0.02 | 11,509 | -74.88% | -$32,600.59 | <0.01 | |
| Bradley Foster Sargent Inc Ct | $9,500.00 | 0.02 | 10,000 | 0% | +$0 | <0.0001 | |
| Tower Research Capital | $7,623.00 | 0.02 | 8,024 | +30.37% | +$1,775.60 | <0.0001 | |
| BNY Mellon | $3,458.00 | 0.01 | 3,640 | -83.77% | -$17,847.65 | <0.0001 | |
| Hexagon Capital Partners Llc | $3,166.00 | 0.01 | 3,333 | 0% | +$0 | <0.01 | |
| Soa Wealth Advisors Llc | $2,111.00 | <0.01 | 2,222 | 0% | +$0 | <0.0001 | |
| Comerica | $795.00 | <0.01 | 837 | +61.27% | +$302.04 | <0.0001 | |
| LAZARD ASSET MANAGEMENT LLC | $1,000.00 | <0.01 | 1,090 | +16.2% | +$139.45 | <0.0001 | |
| JPMorgan Chase | $353.00 | <0.01 | 372 | 0% | +$0 | <0.0001 | |
| Simplex Trading Llc | $0 | <0.01 | 620 | -57.51% | -$0 | <0.0001 | |
| Wells Fargo | $757.00 | <0.01 | 796 | +47.13% | +$242.51 | <0.0001 | |
| Allworth Financial Lp | $36.00 | <0.01 | 37 | 0% | +$0 | <0.0001 | |
| Qube Research & Technologies | $1.00 | <0.01 | 1 | 0% | +$0 | <0.0001 | |
| Royal Bank of Canada | $0 | <0.01 | 93 | +17.72% | +$0 | <0.0001 | |
| PNC Financial Services | $29.00 | <0.01 | 31 | -13.89% | -$4.68 | <0.0001 | |
| UBS | $54.00 | <0.01 | 57 | -98.08% | -$2,751.16 | <0.0001 | |
| Your Advocates Ltd LLP | $238.00 | <0.01 | 250 | 0% | +$0 | <0.0001 |